XMD8-85 – 25 mg

Brand:
Cayman
CAS:
1234479-76-5
Storage:
-20
UN-No:
Non-Hazardous - /

XMD8-85 is an ERK5 inhibitor (IC50 = 87 nM in an enzyme assay).{42420} It is selective for ERK5 over tyrosine non-receptor kinase 2 (TNK2; IC50 = 959 nM), but does inhibit the leucine-rich repeat kinase 2 (LRRK2) mutant LRRK2G2019S (IC50 = 26 nM), which has been found in patients with Parkinson’s disease.{46785,42420} XMD8-85 inhibits EGF-induced ERK5 autophosphorylation in HeLa cells (EC50 = 0.19 μM).{42420}  

 

Available on backorder

SKU: 29662 - 25 mg Category:

Description

An ERK5 inhibitor (IC50 = 87 nM in an enzyme assay); selective for ERK5 over TNK2 (IC50 = 959 nM), but does inhibit LRRK2G2019S (IC50 = 26 nM); inhibits EGF-induced ERK5 autophosphorylation in HeLa cells (EC50 = 0.19 μM)


Formal name: 5,11-dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one

Synonyms:  ERK5-IN-1​

Molecular weight: 459.5

CAS: 1234479-76-5

Purity: ≥98%

Formulation: A solid